Form D · Biotechnology
NANOCOR THERAPEUTICS INC
Chapel Hill, NC · CIK 0001352203
Offering snapshot reported Jun 29, 2009 · SEC filing
- Reported sold
- $6.25M Offering amount: $7.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $2.5M Reported outside-investor minimum
- First sale
- Aug 23, 2007 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 29, 2009 | Initial | $6,250,000 | No comparison | 1 | SEC filing |
| Aug 31, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 26, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-86049
This is intended to be an amendment to an earlier Form D filed 8/31/07; we had technical difficulties filing this as an amendment; SEC staff instructed us to file as a new filing and indicate that it is intended as an amendment.
Source: Form D, filed Jun 29, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gerald Laurence Klein | Director |
| Sheila Ann Mikhail | Director, Executive, Promoter |
| Richard Jude Samulski | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
870 Martin Luther King Jr Blvd
Chapel Hill, NC, 27514
Chapel Hill, NC, 27514